Filter
1630
Filtered Results: 1630
Text search:
Malaria
vaccine
Featured
Recommendations
168
New Publications
523
Language
Document type
No document type
875
Studies & Reports
320
Guidelines
169
Strategic & Response Plan
87
Manuals
81
Fact sheets
34
Training Material
28
Situation Updates
15
Resource Platforms
7
Infographics
7
Brochures
4
Videos
2
Online Courses
1
Countries / Regions
Global
108
India
76
Kenya
56
Liberia
54
Sierra Leone
51
Nigeria
50
Congo, Democratic Republic of
40
Uganda
39
Tanzania
35
Ghana
33
Malawi
33
Africa
32
Nepal
30
Ethiopia
28
Zambia
26
Rwanda
24
South Africa
24
Mozambique
21
Myanmar / Burma
18
Haiti
17
Latin America and the Carribbean
17
Western and Central Europe
17
Bangladesh
17
Senegal
16
Zimbabwe
14
Namibia
14
Asia
13
East and Southern Africa
13
South Sudan
12
Cameroon
11
Burkina Faso
11
Guinea
11
West and Central Africa
11
South–East Asia Region
11
Indonesia
10
Philippines
9
Venezuela
8
Eastern Europe
8
Botswana
8
Pakistan
8
Lesotho
7
Cambodia
7
Togo
6
Middle East and North Africa
6
Madagascar
6
Sudan
5
Thailand
4
Benin
4
Syria
4
Papua New Guinea
4
Brazil
4
Yemen
4
Somalia
4
Eswatini/ Swaziland
4
Laos
3
Niger
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Central African Republic
3
Mali
3
Angola
3
Colombia
2
Timor Leste/ East Timor
2
Ukraine
2
China
2
Afghanistan
2
Peru
2
Malaysia
2
Jordan
2
Saudi Arabia
2
Paraguay
2
Japan
2
Argentina
2
Lebanon
2
Sri Lanka
2
Russia
2
North Macedonia
1
Tajikistan
1
Switzerland
1
El Salvador
1
Gambia
1
Chile
1
Iran
1
Burundi
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Germany
1
France
1
Mauritius
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Vietnam
1
Moldova
1
Djibouti
1
Egypt
1
Palestine
1
Georgia
1
Honduras
1
Chad
1
Libya
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
762
Clinical Guidelines
129
Women & Child Health
86
Public Health
76
Key Resources
53
Capacity Building
19
Pharmacy & Technologies
15
Toolboxes
COVID-19
119
Malaria
92
HIV
87
Ebola & Marburg
80
TB
76
Health Financing Toolbox
57
AMR
54
NTDs
49
Pharmacy
38
Global Health Education
38
Rapid Response
33
Caregiver
30
Planetary Health
27
Conflict
19
Natural Hazards
17
2.0 Rapid Response
17
Mental Health
16
Refugee
14
Cholera
14
Zika
14
Disability
7
NCDs
6
Polio
6
Specific Hazards
3
South Sudan
1
Cette note d'information souligne l'importance d'intégrer une approche sensible au genre dans les efforts de lutte contre le paludisme dans le monde entier. Il montre que la prise en compte des vulnérabilités et des besoins spécifiques à chaque sexe - en particulier ceux des femmes et des enfan...
Le plan stratégique de la RBM Partnership to End Malaria pour 2021-2025 présente les priorités stratégiques du partenariat mondial visant à éliminer le paludisme. Le document se concentre sur trois objectifs stratégiques principaux : optimiser les programmes régionaux et nationaux, maximiser...
Deux vaccins antipaludiques sont actuellement préqualifiés et recommandés par l'OMS1 pour prévenir
le paludisme à P. falciparum chez les jeunes enfants : le vaccin RTS,S/AS01, actuellement fabriqué par
GlaxoSmithKline (GSK), et le vaccin R21/Matrix-M, fabriqué par Serum Institute of India
...
This practical document is available to support programmes and partners to design and implement risk communication strategies to achieve high uptake of malaria vaccination.
The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to improve access to immunization and tackle vaccine-preventable diseases. This responsibility has been translated into firm commitments in February 2016, t...
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Circulating vaccine-derived poliovirus type 2 in Angola
Ebola virus disease in Democratic Republic of the Congo
Dengue fever in Côte d’Ivoire
Humanitarian crisis in north-east Nigeria.
Evidence-based Malaria BCC Module 4 e-learning series.
Accessed July 2025
The document will provide information for Ministries of Health and hospital sentinel sites on why and how to determine the denominator of at-risk children <5 years of age and rate of meningitis hospitalizations for a sentinel hospital site conducting IB-VPD surveillance. Such a methodology is curren...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands...
